191 related articles for article (PubMed ID: 17170744)
1. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S
Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
4. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
5. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
[TBL] [Abstract][Full Text] [Related]
8. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
[TBL] [Abstract][Full Text] [Related]
10. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
[TBL] [Abstract][Full Text] [Related]
12. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
[TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
15. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma.
Dos Santos M; da Cunha Mercante AM; Nunes FD; Leopoldino AM; de Carvalho MB; Gazito D; López RV; Chiappini PB; de Carvalho Neto PB; Fukuyama EE; ; Tajara EH; Louro ID; da Silva AM
Mol Biol Rep; 2012 Dec; 39(12):10157-65. PubMed ID: 22972152
[TBL] [Abstract][Full Text] [Related]
19. TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.
Wang XJ; Li FF; Zhang YJ; Jiang M; Ren WH
Cancer Biomark; 2020; 29(3):307-315. PubMed ID: 32716348
[TBL] [Abstract][Full Text] [Related]
20. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
Huang GW; Ding X; Chen SL; Zeng L
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
